$CRKN
Crown Electrokinetics Corp. Stock $crkn

$crkn Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000176169624000107 Filed on November 15, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$8.037M
YoY Change
Cost Of Revenue		$6.623M
YoY Change
Gross Profit		$1.414M
YoY Change
Gross Profit Margin		17.59%
Selling, General & Admin		$6.507M	$2.941M
YoY Change		121.25%	36.16%
% of Gross Profit		460.18%
Research & Development		$720.0K	$492.0K
YoY Change		46.34%	-48.48%
% of Gross Profit		50.92%
Depreciation & Amortization		$200.0K	$100.0K
YoY Change		100.0%	44.93%
% of Gross Profit		14.14%
Operating Expenses		$7.227M	$3.433M
YoY Change		110.52%	10.21%
Operating Profit		-$5.813M	-$3.433M
YoY Change		69.33%	10.21%
Interest Expense		$0.00	$2.445M
YoY Change		-100.0%	244400.0%
% of Operating Profit
Other Income/Expense, Net		-$51.00K	$574.0K
YoY Change		-108.89%	-57500.0%
Pretax Income		-$5.864M	-$2.859M
YoY Change		105.11%	-8.25%
Income Tax
% Of Pretax Income
Net Earnings		-$5.864M	-$2.859M
YoY Change		105.11%	-8.25%
Net Earnings / Revenue		-72.96%
Basic Earnings Per Share		-$1.26	-$0.94
Diluted Earnings Per Share		-$1.26	-$0.94
COMMON SHARES
Basic Shares Outstanding	9.302M shares	4.390M shares	3.019M shares
Diluted Shares Outstanding		4.662M shares	3.349M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.087M	$2.060M
YoY Change	49.85%	502.34%
Cash & Equivalents	$3.100M	$2.056M
Short-Term Investments
Other Short-Term Assets	$355.0K	$96.00K
YoY Change	269.79%	-74.74%
Inventory
Prepaid Expenses
Receivables	$4.869M
Other Receivables	$158.0K
Total Short-Term Assets	$8.751M	$2.662M
YoY Change	228.74%	268.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.316M	$2.638M
YoY Change	101.52%	86.3%
Goodwill		$652.0K
YoY Change
Intangibles		$1.633M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$191.0K	$33.00K
YoY Change	478.79%	-91.81%
Total Long-Term Assets	$8.873M	$9.504M
YoY Change	-6.64%	74.58%
TOTAL ASSETS
Total Short-Term Assets	$8.751M	$2.662M
Total Long-Term Assets	$8.873M	$9.504M
Total Assets	$17.62M	$12.17M
YoY Change	44.86%	97.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.337M	$1.855M
YoY Change	133.8%	53.18%
Accrued Expenses	$917.0K	$175.0K
YoY Change	424.0%	31.58%
Deferred Revenue	$240.0K
YoY Change
Short-Term Debt	$0.00	$90.00K
YoY Change	-100.0%	1025.0%
Long-Term Debt Due	$128.0K
YoY Change
Total Short-Term Liabilities	$6.261M	$2.537M
YoY Change	146.79%	58.07%
LONG-TERM LIABILITIES
Long-Term Debt	$310.0K	$0.00
YoY Change
Other Long-Term Liabilities	$1.130M	$360.0K
YoY Change	213.89%	-80.17%
Total Long-Term Liabilities	$1.440M	$360.0K
YoY Change	300.0%	-80.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.261M	$2.537M
Total Long-Term Liabilities	$1.440M	$360.0K
Total Liabilities	$7.701M	$2.892M
YoY Change	166.29%	-15.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$132.5M	-$107.7M
YoY Change	23.03%	25.45%
Common Stock	$0.00	$7.000K
YoY Change	-100.0%	250.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.923M	$9.274M
YoY Change
Total Liabilities & Shareholders Equity	$17.62M	$12.17M
YoY Change	44.86%	97.31%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$5.864M	-$2.859M
YoY Change	105.11%	-8.25%
Depreciation, Depletion And Amortization	$200.0K	$100.0K
YoY Change	100.0%	44.93%
Cash From Operating Activities	-$2.909M	-$3.420M
YoY Change	-14.94%	62.39%
INVESTING ACTIVITIES
Capital Expenditures	$2.067M	$370.0K
YoY Change	458.65%	-1950.0%
Acquisitions
YoY Change
Other Investing Activities	-$158.0K	-$10.00K
YoY Change	1480.0%
Cash From Investing Activities	-$2.225M	-$380.0K
YoY Change	485.53%	1800.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.231M	5.820M
YoY Change	-27.3%	292.18%
NET CHANGE
Cash From Operating Activities	-2.909M	-3.420M
Cash From Investing Activities	-2.225M	-380.0K
Cash From Financing Activities	4.231M	5.820M
Net Change In Cash	-903.0K	2.020M
YoY Change	-144.7%	-414.64%
FREE CASH FLOW
Cash From Operating Activities	-$2.909M	-$3.420M
Capital Expenditures	$2.067M	$370.0K
Free Cash Flow	-$4.976M	-$3.790M
YoY Change	31.29%	81.69%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Entity File Number EntityFileNumber	333-232426
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-5423944
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1110 NE Circle Blvd
	dei	Entity Address City Or Town EntityAddressCityOrTown	Corvallis
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3087000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	83000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6261000	usd
CY2024Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	310000	usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001761696
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	Crown Electrokinetics Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Address State Or Province EntityAddressStateOrProvince	OR
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	97330
	dei	City Area Code CityAreaCode	458
	dei	Local Phone Number LocalPhoneNumber	212.2500
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value
	dei	Trading Symbol TradingSymbol	CRKN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9301635	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1059000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	8751000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1870000	usd
CY2024Q3	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	210000	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	0	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5316000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3129000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1213000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1382000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1701000	usd
CY2024Q3	us-gaap	Deferred Costs DeferredCosts	223000	usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts	1306000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	191000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	139000	usd
CY2024Q3	us-gaap	Assets Assets	17624000	usd
CY2023Q4	us-gaap	Assets Assets	9527000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4337000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1500000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	917000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1194000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	639000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	655000	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	128000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	429000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	240000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3778000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.00667
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4869000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	255000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	382000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	728000	usd
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	158000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	0	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1720000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1130000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1072000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	7701000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4850000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6708113	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6708113	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	171677	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	171677	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	142423000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	121665000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-132500000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116995000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	9923000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4677000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17624000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9527000	usd
CY2024Q3	us-gaap	Revenues Revenues	8037000	usd
CY2023Q3	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	13367000	usd
	us-gaap	Revenues Revenues	59000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	6623000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
	us-gaap	Cost Of Revenue CostOfRevenue	12442000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	54000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	1414000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	0	usd
	us-gaap	Gross Profit GrossProfit	925000	usd
	us-gaap	Gross Profit GrossProfit	5000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	720000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	492000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1945000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1523000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6507000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2941000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13405000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10926000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	7227000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	3433000	usd
	us-gaap	Operating Expenses OperatingExpenses	15350000	usd
	us-gaap	Operating Expenses OperatingExpenses	12449000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5813000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3433000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14425000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12444000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	0	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2445000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1001000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	6970000	usd
CY2024Q3	crkn	Loss On Extinguishment Of Warrant Liability LossOnExtinguishmentOfWarrantLiability	0	usd
CY2023Q3	crkn	Loss On Extinguishment Of Warrant Liability LossOnExtinguishmentOfWarrantLiability	0	usd
	crkn	Loss On Extinguishment Of Warrant Liability LossOnExtinguishmentOfWarrantLiability	0	usd
	crkn	Loss On Extinguishment Of Warrant Liability LossOnExtinguishmentOfWarrantLiability	504000	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2345000	usd
CY2024Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	64000	usd
CY2024Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2688000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10424000	usd
CY2024Q3	crkn	Change In Fair Value Of Notes1 ChangeInFairValueOfNotes1	0	usd
CY2023Q3	crkn	Change In Fair Value Of Notes1 ChangeInFairValueOfNotes1	-40000	usd
	crkn	Change In Fair Value Of Notes1 ChangeInFairValueOfNotes1	0	usd
	crkn	Change In Fair Value Of Notes1 ChangeInFairValueOfNotes1	-7040000	usd
CY2024Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	401000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	401000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-51000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-30000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-79000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1264000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-51000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	574000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1080000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7234000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-5864000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2859000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15505000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19678000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5864000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3142000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21230000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20154000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.26
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-140.54
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-9.54
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1941.24
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4662086	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4662086	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22356	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22356	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2224477	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2224477	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10382	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10382	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4677000	usd
CY2024Q1	crkn	Stock Issuance Of Common Stockequity Line Of Credit Net Of Offering Costs StockIssuanceOfCommonStockequityLineOfCreditNetOfOfferingCosts	1391000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	588000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	274000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4612000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	2318000	usd
CY2024Q2	crkn	Stock Issuance Of Common Stockequity Line Of Credit Net Of Offering Costs StockIssuanceOfCommonStockequityLineOfCreditNetOfOfferingCosts	9343000	usd
CY2024Q2	crkn	Adjustments To Additional Paid In Capital Reverse Stock Split AdjustmentsToAdditionalPaidInCapitalReverseStockSplit	0	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2150000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-5029000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	8782000	usd
CY2024Q3	crkn	Stock Issuance Of Common Stockequity Line Of Credit Net Of Offering Costs StockIssuanceOfCommonStockequityLineOfCreditNetOfOfferingCosts	3606000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1183000	usd
CY2024Q3	crkn	Stock Issued During Period Value Issuance Of Common Stock In Connection With Inducement Award StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithInducementAward	292000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1861000	usd
CY2024Q3	crkn	Stock Issued During Period Value Issuance Of Common Stock In Connection With Warrant Exchange StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithWarrantExchange	63000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-5864000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	9923000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	530000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2062000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	516000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2107000	usd
CY2023Q1	crkn	Stock Issued During Period Value Issuance Of Series E Preferred Stock In Connection With Loc StockIssuedDuringPeriodValueIssuanceOfSeriesEPreferredStockInConnectionWithLOC	4350000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	298000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	181000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2300000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	7744000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1000	usd
CY2023Q2	crkn	Issuance Of Common Stock In Connection With Conversion Of2022 Notes IssuanceOfCommonStockInConnectionWithConversionOf2022Notes	2166000	usd
CY2023Q2	crkn	Stock Issued During Period Value Series D Preferred Stock Exchanged For Series F Preferred Stock In Connection With Exchange Agreement StockIssuedDuringPeriodValueSeriesDPreferredStockExchangedForSeriesFPreferredStockInConnectionWithExchangeAgreement	-450000	usd
CY2023Q2	crkn	Conversion Of Demand Notes And October Notes Into Series F Preferred Stock In Connection With Exchange Agreements Value ConversionOfDemandNotesAndOctoberNotesIntoSeriesFPreferredStockInConnectionWithExchangeAgreementsValue	1276000	usd
CY2023Q2	crkn	Conversion Of January Notes Into Series F Preferred Stock In Connection With Exchange Agreements Value ConversionOfJanuaryNotesIntoSeriesFPreferredStockInConnectionWithExchangeAgreementsValue	82000	usd
CY2023Q2	crkn	Stock Issued During Period Value Issuance Of Series F1 Preferred Stock StockIssuedDuringPeriodValueIssuanceOfSeriesF1PreferredStock	1372000	usd
CY2023Q2	crkn	Stock Issued During Period Value Issuance Of Series F2 Preferred Stock StockIssuedDuringPeriodValueIssuanceOfSeriesF2PreferredStock	464000	usd
CY2023Q2	crkn	Commitment To Issue Shares Of Common Stock In Connection With Senior Secured Notes CommitmentToIssueSharesOfCommonStockInConnectionWithSeniorSecuredNotes	2410000	usd
CY2023Q2	crkn	Stock Issued During Period Value Credit Notes Common Stock Commitment Share Issuance StockIssuedDuringPeriodValueCreditNotesCommonStockCommitmentShareIssuance	230000	usd
CY2023Q2	crkn	Stock Issued During Period Commitment To Issue Shares Of Series E Preferred Stock In Connection With Line Of Credit Notes StockIssuedDuringPeriodCommitmentToIssueSharesOfSeriesEPreferredStockInConnectionWithLineOfCreditNotes	3363000	usd
CY2023Q2	crkn	Stock Issued During Period Commitment To Issue Shares Of Common Stock In Connection With Demand Notes StockIssuedDuringPeriodCommitmentToIssueSharesOfCommonStockInConnectionWithDemandNotes	286000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	132000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-14519000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	4557000	usd
CY2023Q3	crkn	Issuance Of Common Stock In Connection With Notes Settlement Value IssuanceOfCommonStockInConnectionWithNotesSettlementValue	1160000	usd
CY2023Q3	crkn	Issuance Of Common Stock In Connection With Equity Line Of Credit Issuance Costs Value IssuanceOfCommonStockInConnectionWithEquityLineOfCreditIssuanceCostsValue	114000	usd
CY2023Q3	crkn	Issuance Of Common Stock Under The Equity Line Of Credit Net Of Issuance Costs Value IssuanceOfCommonStockUnderTheEquityLineOfCreditNetOfIssuanceCostsValue	4489000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1680000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	133000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2859000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	9274000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15505000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19678000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4577000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	446000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	694000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	542000	usd
	crkn	Loss On Extinguishment Of Warrant Liability LossOnExtinguishmentOfWarrantLiability	0	usd
	crkn	Loss On Extinguishment Of Warrant Liability LossOnExtinguishmentOfWarrantLiability	504000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10424000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	401000	usd
	crkn	Gain On Issuance Of Convertible Note GainOnIssuanceOfConvertibleNote	0	usd
	crkn	Gain On Issuance Of Convertible Note GainOnIssuanceOfConvertibleNote	64000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2345000	usd
	crkn	Change In Fair Value Of Notes ChangeInFairValueOfNotes	0	usd
	crkn	Change In Fair Value Of Notes ChangeInFairValueOfNotes	-7040000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1083000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	6800000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	541000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	339000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-380000	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	63000	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	467000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-84000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-136000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4786000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	255000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	0	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	240000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2297000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	732000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-277000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-575000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-518000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-398000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11762000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11809000	usd
	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	0	usd
	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	645000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2123000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1084000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	243000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	85000	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2281000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1729000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2062000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1771000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3787000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2350000	usd
	crkn	Proceeds From Issuance Of Series F1 Preferred Stock Net Of Fees ProceedsFromIssuanceOfSeriesF1PreferredStockNetOfFees	0	usd
	crkn	Proceeds From Issuance Of Series F1 Preferred Stock Net Of Fees ProceedsFromIssuanceOfSeriesF1PreferredStockNetOfFees	2328000	usd
	crkn	Proceeds From Issuance Of Series F2 Preferred Stock ProceedsFromIssuanceOfSeriesF2PreferredStock	0	usd
	crkn	Proceeds From Issuance Of Series F2 Preferred Stock ProceedsFromIssuanceOfSeriesF2PreferredStock	748000	usd
	crkn	Proceeds From Issuance Of Senior Secured Notes Net Of Fees Paid ProceedsFromIssuanceOfSeniorSecuredNotesNetOfFeesPaid	0	usd
	crkn	Proceeds From Issuance Of Senior Secured Notes Net Of Fees Paid ProceedsFromIssuanceOfSeniorSecuredNotesNetOfFeesPaid	1357000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	40000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2348000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1118000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1118000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
	crkn	Proceeds From The Issuance Of Common Stock In Connection With Equity Line Of Credit Net Of Offering ProceedsFromTheIssuanceOfCommonStockInConnectionWithEquityLineOfCreditNetOfOffering	14340000	usd
	crkn	Proceeds From The Issuance Of Common Stock In Connection With Equity Line Of Credit Net Of Offering ProceedsFromTheIssuanceOfCommonStockInConnectionWithEquityLineOfCreditNetOfOffering	4489000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16071000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14773000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2028000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1235000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1059000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	821000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3087000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2056000	usd
	us-gaap	Interest Paid Net InterestPaidNet	150000	usd
	us-gaap	Interest Paid Net InterestPaidNet	9000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	2000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	560000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	crkn	Reduction Of Right Of Use Asset And Operating Lease Liability Due To Early Lease Termination ReductionOfRightOfUseAssetAndOperatingLeaseLiabilityDueToEarlyLeaseTermination	0	usd
	crkn	Reduction Of Right Of Use Asset And Operating Lease Liability Due To Early Lease Termination ReductionOfRightOfUseAssetAndOperatingLeaseLiabilityDueToEarlyLeaseTermination	802000	usd
	crkn	Net Impact Of Reverse Stock Splits NetImpactOfReverseStockSplits	10000	usd
	crkn	Net Impact Of Reverse Stock Splits NetImpactOfReverseStockSplits	0	usd
	crkn	Issuance Of Common Stock In Connection With Conversion Of Line Of Credit IssuanceOfCommonStockInConnectionWithConversionOfLineOfCredit	0	usd
	crkn	Issuance Of Common Stock In Connection With Conversion Of Line Of Credit IssuanceOfCommonStockInConnectionWithConversionOfLineOfCredit	4350000	usd
	crkn	Issuance Of Common Stock In Connection With Equity Line Of Credits IssuanceOfCommonStockInConnectionWithEquityLineOfCredits	0	usd
	crkn	Issuance Of Common Stock In Connection With Equity Line Of Credits IssuanceOfCommonStockInConnectionWithEquityLineOfCredits	114000	usd
	crkn	Issuance Of Preferred Stock In Connection With Exchange IssuanceOfPreferredStockInConnectionWithExchange	0	usd
	crkn	Issuance Of Preferred Stock In Connection With Exchange IssuanceOfPreferredStockInConnectionWithExchange	450000	usd
	crkn	Issuance Of Common Stock In Connection With Conversion Of Notes IssuanceOfCommonStockInConnectionWithConversionOfNotes	0	usd
	crkn	Issuance Of Common Stock In Connection With Conversion Of Notes IssuanceOfCommonStockInConnectionWithConversionOfNotes	2681000	usd
	crkn	Issuance Of Common Stock In Connection With Senior Secured Notes Settlement IssuanceOfCommonStockInConnectionWithSeniorSecuredNotesSettlement	0	usd
	crkn	Issuance Of Common Stock In Connection With Senior Secured Notes Settlement IssuanceOfCommonStockInConnectionWithSeniorSecuredNotesSettlement	1160000	usd
	crkn	Conversion Of Senior Secured Notes Into Series F Preferred Stock In Connection With Exchange ConversionOfSeniorSecuredNotesIntoSeriesFPreferredStockInConnectionWithExchange	0	usd
	crkn	Conversion Of Senior Secured Notes Into Series F Preferred Stock In Connection With Exchange ConversionOfSeniorSecuredNotesIntoSeriesFPreferredStockInConnectionWithExchange	82000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	540000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	23000	usd
	us-gaap	Notes Issued1 NotesIssued1	49000	usd
	us-gaap	Notes Issued1 NotesIssued1	0	usd
	crkn	Commitment To Issue Shares Of Common Stock In Connection With Demand Notes CommitmentToIssueSharesOfCommonStockInConnectionWithDemandNotes	0	usd
	crkn	Commitment To Issue Shares Of Common Stock In Connection With Demand Notes CommitmentToIssueSharesOfCommonStockInConnectionWithDemandNotes	286000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3100000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-132500000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15500000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11800000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Accounting estimates and assumptions are inherently uncertain. Management bases its estimates and assumptions on current facts, historical experience and various other factors believed to be reasonable under the circumstances. Actual results could differ materially and adversely from these estimates. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but not limited to, cost-to-cost (input) revenue recognition method, fair value of warrant issuances, provision for expected credit losses, useful lives and recoverability of long-lived assets, valuation of deferred tax assets, stock-based compensation and operating lease right-of-use assets and liabilities.</span></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to the condensed consolidated statement of cash flows for the nine months ended September 30, 2023 for consistency with the presentation of the condensed consolidated statement of cash flows for the nine months ended September 30, 2024. There was no effect on the Company's financial position or stockholders' equity as of September 30, 2024 and December 31, 2023 or the results of operations for the three and nine months ended September 30, 2024 and 2023.</span></div>
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	segment
CY2024Q3	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	300000	usd
CY2023Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	0	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
	crkn	Contract With Customer Asset Revenue Recognized Prior To Billings ContractWithCustomerAssetRevenueRecognizedPriorToBillings	1109000	usd
	crkn	Contract With Customer Asset Billings ContractWithCustomerAssetBillings	854000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	255000	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	200000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
	crkn	Contract With Customer Liability Billings ContractWithCustomerLiabilityBillings	1260000	usd
	crkn	Contract With Customer Liability Revenue Recognized Prior To Billings ContractWithCustomerLiabilityRevenueRecognizedPriorToBillings	1020000	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	240000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Risk and Significant Customers</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains its cash accounts with financial institutions, ensuring all deposits remain fully protected by utilizing ICS/Sweep accounts. As a result, no cash balances exceed the Federal Deposit Insurance Corporation limits, providing complete coverage and safeguarding the Company's funds through September 30, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s customers are generally large public or private companies with good credit and payment practices and a positive reputation in the industry at the time that the contracts are entered into. Furthermore, because it has the ability to stop transferring promised goods and services if payment is not received, the Company has concluded that collection risk is minimal.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three customers accounted for 91% of accounts receivable as of September 30, 2024. Accounts receivable were not significant as of December 31, 2023.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s revenue is generated from its Fiber Optics, Slant Wells, and Element 82 segments. Three customers accounted for approximately 95% and 84% of the total revenue generated for the three and nine months ended September 30, 2024, respectively. Revenue was not significant for the three and nine months ended September 30, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2024, the Company’s vendor purchases primarily included costs associated with professional fees, subcontractor labor, equipment purchases and leases, and purchases of other supplies and materials. Any disruptions in the Company’s vendor relationships could have a material adverse effect on the Company’s business, results of operations and financial condition.</span></div>
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2024Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	500000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1052408	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	24139	shares
CY2024Q3	us-gaap	Revenues Revenues	8000000.0	usd
CY2023Q3	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	13400000	usd
	us-gaap	Revenues Revenues	100000	usd
CY2024Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3100000	usd
CY2024Q3	crkn	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Percentage RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPercentage	1
CY2024Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2024Q3	crkn	Prepaid License Fees PrepaidLicenseFees	16000	usd
CY2023Q4	crkn	Prepaid License Fees PrepaidLicenseFees	158000	usd
CY2024Q3	us-gaap	Prepaid Rent PrepaidRent	11000	usd
CY2023Q4	us-gaap	Prepaid Rent PrepaidRent	277000	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	355000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	293000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	382000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	728000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6760000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4048000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1444000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	919000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5316000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3129000	usd
CY2024Q3	us-gaap	Depreciation Depreciation	200000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	100000	usd
	us-gaap	Depreciation Depreciation	500000	usd
	us-gaap	Depreciation Depreciation	300000	usd
CY2024Q3	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1800000	usd
CY2023Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1800000	usd
CY2024Q3	crkn	Finite Lived Intangible Assets Research License Gross FiniteLivedIntangibleAssetsResearchLicenseGross	375000	usd
CY2023Q4	crkn	Finite Lived Intangible Assets Research License Gross FiniteLivedIntangibleAssetsResearchLicenseGross	375000	usd
CY2024Q3	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	4000	usd
CY2023Q4	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	4000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2179000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2179000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	966000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	797000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1213000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1382000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	55000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	220000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	183000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	180000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	180000	usd
CY2024Q3	crkn	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	395000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1213000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	usd
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y9M14D
CY2024Q3	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Gross DebtIssuanceCostsLineOfCreditArrangementsGross	10647000	usd
CY2023Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Gross DebtIssuanceCostsLineOfCreditArrangementsGross	10647000	usd
CY2024Q3	us-gaap	Accumulated Amortization Of Debt Issuance Costs Line Of Credit Arrangements AccumulatedAmortizationOfDebtIssuanceCostsLineOfCreditArrangements	10424000	usd
CY2023Q4	us-gaap	Accumulated Amortization Of Debt Issuance Costs Line Of Credit Arrangements AccumulatedAmortizationOfDebtIssuanceCostsLineOfCreditArrangements	9341000	usd
CY2024Q3	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	223000	usd
CY2023Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	1306000	usd
CY2024Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	109000	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	112000	usd
CY2024Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	0	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1000000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	808000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	82000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	917000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1194000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	67000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	81000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	76000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	71000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	65000	usd
CY2024Q3	crkn	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	78000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	438000	usd
CY2024Q2	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.0462
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2578	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9867.85
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M6D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1667	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	13.50
	crkn	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P9Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	200	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	28.50
	crkn	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm	P9Y2M12D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4045	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6293.23
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M6D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2299	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	10995.62
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y2M12D
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	47000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1667	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.957
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.049
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y9M18D
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2153000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	133000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4577000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	446000	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	214000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	108000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	696000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	439000	usd
CY2024Q3	us-gaap	Variable Lease Cost VariableLeaseCost	0	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	25000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	20000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	74000	usd
CY2024Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1282000	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2263000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	usd
CY2024Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	1496000	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	133000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	2979000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	513000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	694000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	513000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	560000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M12D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y8M12D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.120
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.120
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	218000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	774000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	680000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	410000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2082000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	313000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1769000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2024Q3	us-gaap	Revenues Revenues	8037000	usd
CY2023Q3	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	13367000	usd
	us-gaap	Revenues Revenues	59000	usd
CY2024Q3	us-gaap	Revenues Revenues	8037000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	6623000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	1414000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	720000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6507000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	7227000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5813000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	0	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-51000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-51000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-5864000	usd
CY2023Q3	us-gaap	Revenues Revenues	0	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	0	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	492000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2941000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	3433000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3433000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2445000	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2688000	usd
CY2023Q3	crkn	Change In Fair Value Of Notes1 ChangeInFairValueOfNotes1	-40000	usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	401000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-30000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	574000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2859000	usd
	us-gaap	Revenues Revenues	13367000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	12442000	usd
	us-gaap	Gross Profit GrossProfit	925000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1945000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13405000	usd
	us-gaap	Operating Expenses OperatingExpenses	15350000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14425000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1001000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-79000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1080000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15505000	usd
	us-gaap	Revenues Revenues	59000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	54000	usd
	us-gaap	Gross Profit GrossProfit	5000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1523000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10926000	usd
	us-gaap	Operating Expenses OperatingExpenses	12449000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12444000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	6970000	usd
	crkn	Loss On Extinguishment Of Warrant Liability LossOnExtinguishmentOfWarrantLiability	504000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2345000	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	64000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10424000	usd
	crkn	Change In Fair Value Of Notes1 ChangeInFairValueOfNotes1	-7040000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	401000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1264000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7234000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19678000	usd

Files In Submission

Name	View Source	Status
0001761696-24-000107-index-headers.html	Edgar Link	pending
0001761696-24-000107-index.html	Edgar Link	pending
0001761696-24-000107.txt	Edgar Link	pending
0001761696-24-000107-xbrl.zip	Edgar Link	pending
crkn-20240930.htm	Edgar Link	pending
crkn-20240930.xsd	Edgar Link	pending
crkn-20240930xex311.htm	Edgar Link	pending
crkn-20240930xex312.htm	Edgar Link	pending
crkn-20240930xex321.htm	Edgar Link	pending
crkn-20240930xex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
crkn-20240930_cal.xml	Edgar Link	unprocessable
crkn-20240930_def.xml	Edgar Link	unprocessable
crkn-20240930_lab.xml	Edgar Link	unprocessable
crkn-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
crkn-20240930_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRKN
Crown Electrokinetics Corp. Stock $crkn

2024 Q4 Form 10-Q Financial Statement

#000176169624000107 Filed on November 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRKN Crown Electrokinetics Corp. Stock $crkn

2024 Q4 Form 10-Q Financial Statement

#000176169624000107 Filed on November 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRKN
Crown Electrokinetics Corp. Stock $crkn